How do you approach adjuvant therapy for a premenopausal patient with a pathologic BRCA1 mutation whose TNBC had a complete response to neoadjuvant chemotherapy except for an ITC in one LN?  

Patient was given ddAC + T



Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Community Practice